Conferences

A potentially groundbreaking new treatment for ocular melanoma (OM) has reached the first phase of its clinical trial.

Scientists have developed gene-carrying nanoparticles that have the potential to cure a leading cause of blindness in children.

After each new intake of Certificate IV students of optical dispensing, Randwick TAFEhosts an Industry Day. LEWIS WILLIAMS reports on...

ASX-listed Visioneering Technologies (VTI) has signed a sales and distribution deal with Japan’s largest contact lens company, mapping a path...

A joint Australian-Brazilian research project has for the first time identified the molecular mechanism behind the characteristic retinal lesions and...

In a study that could help significantly reshape public health policy in both countries, Centre for Eye Research Australia (CERA)...

Under the agreent, the ABF will cease operation at 30 June, and fold into Vision 2020 Australia as the organisations...

Newly published research from Essilor has suggested an investment of US $14 billion (AU$21 b) over the next 30 years...

From only three qualified optometrists in 2013, Vietnam is now welcoming the first round of locally trained clinicians into the...

A significant Australian study into the effectiveness of Allergan’s Ozurdex implant as a treatment for Diabetic Macular Oedema (DME) has...